There are 2137 resources available
1072P - Beyond classical surrogate endpoints in trials of PD1/PD-L1 immune checkpoint inhibitors (ICI) plus chemotherapy (CT)
Presenter: Guillermo Villacampa Javierre
Session: E-Poster Display
Resources:
Abstract
1073TiP - A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours
Presenter: John Powderly
Session: E-Poster Display
Resources:
Abstract
1074TiP - SGNTGT-001: A phase I study of SGN-TGT, an effector-function enhanced monoclonal antibody (mAb), in advanced malignancies
Presenter: Elena Garralda
Session: E-Poster Display
Resources:
Abstract
1075TiP - MEDI1191, a novel IL-12 mRNA therapy for intratumoral (IT) injection for advanced solid tumours
Presenter: Thomas Marron
Session: E-Poster Display
Resources:
Abstract
1084P - Cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma (mCSCC): Preliminary safety and efficacy results from a phase I clinical trial
Presenter: Philip Clingan
Session: E-Poster Display
Resources:
Abstract
1085P - Health-related quality of life in stage III melanoma patients treated with neoadjuvant ipilimumab and nivolumab followed by index lymph node excision only versus therapeutic lymph node dissection: 24-week results of the PRADO trial
Presenter: Noelle Van Den Heuvel
Session: E-Poster Display
Resources:
Abstract
1086P - Cemiplimab for advanced cutaneous squamous cell carcinoma: Real life experience
Presenter: Candice Hober
Session: E-Poster Display
Resources:
Abstract
1087P - Time to clinically meaningful changes in pain in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab in a phase II clinical trial
Presenter: Michael R Migden
Session: E-Poster Display
Resources:
Abstract
1091P - Performance of Salamanca's refinement of the AJCC8 for T3 cutaneous squamous cell carcinoma (CSCC), versus the Brigham and Women's Hospital's alternative staging system and the Tübingen's alternative staging system for high-risk CSCC
Presenter: Laura Puebla-Tornero
Session: E-Poster Display
Resources:
Abstract
1093P - The features of the tumour microenvironment and the tumour budding identify prognostic subgroups in high-risk cutaneous squamous cell carcinoma
Presenter: Javier Cañueto
Session: E-Poster Display
Resources:
Abstract